Standard Operating Procedure for Osmolality Measurement in Sterile Products in Analytical Method Development
| Department | Analytical Method Development |
|---|---|
| SOP No. | SOP/AMD/269/2025 |
| Supersedes | SOP/AMD/269/2022 |
| Page No. | Page 1 of 11 |
| Issue Date | 21/05/2025 |
| Effective Date | 23/05/2025 |
| Review Date | 21/05/2026 |
1. Purpose
To outline a validated procedure for determining the osmolality of sterile injectable pharmaceutical products using a freezing point depression osmometer, to ensure formulation safety, comfort, and compatibility with physiological
2. Scope
This SOP is applicable to the Analytical Method Development (AMD) and Quality Control (QC) departments for the analysis and validation of osmolality measurements in parenteral dosage forms, including solutions, emulsions, and suspensions.
3. Responsibilities
- Analytical Scientist: Performs osmolality testing using a calibrated osmometer and documents results.
- QC Analyst: Prepares test samples and reference standards for measurement.
- QA Executive: Reviews test records and ensures adherence to regulatory and compendial requirements.
4. Accountability
The Head of Analytical Method Development is accountable for ensuring the method is validated, suitable for intended use, and compliant with pharmacopeial standards.
5. Procedure
5.1 Principle
Osmolality is measured based on the depression of the freezing point of a solution relative to pure solvent, expressed in milliosmoles per kilogram of water (mOsm/kg H2O).
5.2 Equipment and Materials
- Freezing Point Depression Osmometer (e.g., Advanced Instruments or equivalent)
- Calibrated osmolality reference standards (100, 290, and 1000 mOsm/kg)
- Sterile syringes, vials, and sample tubes
5.3 Calibration
- Calibrate osmometer using three-point standardization (100, 290, 1000 mOsm/kg) before use (Annexure-2).
- Acceptable recovery: ±2% of nominal value.
- Recalibrate daily or after 20 consecutive runs.
5.4 Sample Preparation
- Use 100–250 µL of the injection sample directly or diluted as per formulation requirement.
- Degas or equilibrate to room temperature (20–25°C) before analysis.
- Handle under aseptic conditions to avoid contamination.
5.5 Test Execution
- Clean the sample probe with WFI and wipe dry before and after each test.
- Aspirate the sample into the sample holder using a micropipette.
- Insert into the osmometer; initiate automatic freezing and readout.
- Document osmolality value in mOsm/kg with sample ID, batch number, and operator initials.
5.6 Acceptance Criteria
- Isotonic range: 270–310 mOsm/kg H2O (physiological tolerance)
- For hypertonic/hypotonic products, permissible range defined in product specification dossier
- Deviation from specification requires justification and impact assessment on safety/efficacy
5.7 Method Validation Parameters
- Accuracy: Recovery within ±2% of standard values
- Precision: RSD ≤1.5% over 6 replicate injections
- Linearity: r² ≥ 0.999 between 100–1000 mOsm/kg
- Robustness: Test reproducibility under temperature and time delays
6. Abbreviations
- QA: Quality Assurance
- WFI: Water for Injection
- RSD: Relative Standard Deviation
- mOsm/kg: Milliosmoles per Kilogram
7. Documents
- Osmolality Test Log – Annexure-1
- Calibration Certificate – Annexure-2
- Validation Summary Report – Annexure-3
8. References
- USP <785>: Osmolality and Osmolarity
- Ph. Eur. 2.2.35: Osmolality
- ICH Q2(R1): Validation of Analytical Procedures
9. SOP Version
Version: 2.0
10. Approval Section
| Prepared By | Checked By | Approved By | |
|---|---|---|---|
| Signature | |||
| Date | |||
| Name | Anuradha Tiwari | Mahesh Pillai | Sunita Reddy |
| Designation | Senior Analyst | QA Reviewer | Head – AMD |
| Department | Analytical Method Development | QA | Analytical Method Development |
11. Annexures
Annexure-1: Osmolality Test Log
| Sample ID | Batch No. | Volume Tested (µL) | Osmolality (mOsm/kg) | Status |
|---|---|---|---|---|
| INJ-269-01 | 21052302 | 100 | 288 | Pass |
Annexure-2: Calibration Certificate
| Standard Value (mOsm/kg) | Observed Value | Recovery (%) | Status |
|---|---|---|---|
| 100 | 99.2 | 99.2% | Pass |
| 290 | 292.5 | 100.9% | Pass |
| 1000 | 1003 | 100.3% | Pass |
Annexure-3: Validation Summary Report
The osmolality method for injectable formulations including sodium chloride injection and multivitamin preparations was validated. Accuracy (99–101%), precision (RSD = 1.2%), and robustness across multiple analysts were confirmed. Method approved for routine QC and stability programs.
Revision History:
| Revision Date | Revision No. | Details | Reason | Approved By |
|---|---|---|---|---|
| 21/05/2025 | 2.0 | Updated calibration procedure and validation parameters | Annual Review | Sunita Reddy |
| 20/03/2022 | 1.0 | Initial SOP Release | New SOP | QA Head |